Skip to content
Friday, November 13, 2026
Discover handcrafted fruit bouquets and luxury hampers in L…

Zimbabwe Declines ‘Lopsided’ US Health Aid Agreement Over Information Fears

Medical aid illustration
The proposed US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a substantial US healthcare agreement worth $367m (£272m) spanning five years due to the United States' demand for confidential biological samples.

This move was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".

An official spokesman has since explained that the United States was seeking genetic material for research and commercial purposes while refused to guarantee the benefits from future medical innovations.

"We are forced to start the challenging and unfortunate task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for further negotiations to find a agreement suitable to both sides so the nation's vital HIV programme can proceed.

Broader Background

This rejection comes after a similar situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were filed about the safety of citizens' health data.

After resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.

Based on reports, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.

Details of the Declined Deal

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".

"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our people if a new health crisis arise."

National Interest and Global Health

He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures already set up via the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.

"This system is intended to ensure that when a country contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."

The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.

"We encourage further discussions with our US partners on how future collaboration could be structured in a manner that honours the sovereignty and dignity of both nations."

Medical Community Reaction

A leading public health body expressed it understood the official position, but recommended that negotiations must proceed considering much of the country's HIV programmes were funded by external financing.

"Where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group said.

The halted deal emphasises the continuing challenges between accepting much-needed international aid and protecting a country's data in an ever more interconnected world.

XT
By

Xavier Torres

Creative fruit artist and founder of London Fruit Studio, passionate about edible art and healthy gifting.

London Fruit Studio

Type to search articles.